NUVB
Nuvation Bio Inc
5.70$
+0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5,692.8% | -5,947.7% | -2,601.0% | -4,275.8% | -810.8% | -1,382.2% | -996.9% | -403.1% | -71.0% | 6.1% | -16.0% | -48.6% | |
| – | 20.8% | 22.0% | 17.0% | 22.3% | 3.8% | 10.1% | 7.4% | 4.1% | -2.9% | 0.6% | -1.7% | -0.4% | |
| – | 1,409.8% | 1,909.5% | 666.8% | 1,028.3% | 178.4% | 254.7% | 248.9% | 61.1% | -66.7% | 10.9% | -28.5% | -11.7% | |
| – | -545.8% | -1,745.8% | -426.8% | 683.9% | -118.1% | 89.5% | 4.0% | -66.0% | 13.6% | -13.8% | 36.3% | -1.7% | |
| – | 4.9% | 10.2% | 0.0% | 20.4% | 0.2% | 2.3% | 3.7% | 0.1% | 0.2% | 0.1% | 0.2% | 0.1% | |
| – | 12,561.7% | 2,856.8% | 2,388.4% | 4,005.0% | 906.5% | 1,756.9% | 1,135.4% | -736.4% | 208.0% | -52.4% | 18.9% | -27.8% | |
| – | – | – | – | – | – | – | – | – | – | – | -54.1% | – | |
| – | – | – | – | -441.3% | -36.1% | -17.3% | 1,008.4% | 0.0% | 0.0% | 0.0% | 584.0% | 108.9% | |
| – | 45.5% | 8.0% | 191.5% | -211.6% | -15.8% | 17.8% | 4,002.1% | 3.8% | 19.3% | 0.1% | 538.2% | 105.4% | |
| – | 6,914.4% | -3,083.0% | -15.7% | -584.5% | 99.6% | 397.3% | 4,138.1% | -1,136.2% | 155.7% | -46.5% | 540.0% | 28.6% | |
| – | -5,697.7% | -5,958.0% | -2,601.0% | -4,296.1% | -810.5% | -1,384.5% | -1,000.6% | -403.2% | -71.2% | 6.0% | -15.8% | -48.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.